Live Poll Results — Which external partnerships do you consider most valuable for advancing pharmace
See real-time poll results. Powered by AIPolls.Net.
Pharmaceutical R&D Collaboration Preferences
This survey aims to understand how pharmaceutical professionals prefer to collaborate with external partners during the drug development process. Your insights will help improve collaboration frameworks across the industry.
Which external partnerships do you consider most valuable for advancing pharmaceutical innovation?
Poll Type: Custom | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| Academic research institutions | 0 | 0% |
| Contract Research Organizations (CROs) | 0 | 0% |
| Biotech startups with specialized technologies | 0 | 0% |
| Patient advocacy groups | 0 | 0% |
| Technology companies (AI, data analytics, etc.) | 0 | 0% |